Abstract
On March 26, 2020, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington released a website that forecasts coronavirus disease (COVID-19) healthcare demand and mortality for all states in the United States. In light of the popular appeal of the IHME model and considerable scrutiny from the scientific community, we have developed an alternative curve-fitting method for forecasting COVID-19 mortality throughout the US. Our model is similar in spirit to the IHME model, but different in two important details. First, for each US state, we use local data from mobile-phone GPS traces made available by SafeGraph to quantify the changing impact of social-distancing measures on “flattening the curve.” Second, we reformulated the approach in a generalized linear model framework to correct a statistical flaw that leads to the underestimation of uncertainty in the IHME forecasts. The incorporation of real-time geolocation data and several key modifications yields projections that differ noticeably from the IHME model, especially regarding uncertainty when projecting COVID-19 deaths several weeks into the future.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partially funded by grants from the National Science Foundation, the National Institutes of Health, and by a gift from Tito’s Handmade Vodka to the UT COVID-19 Modeling Consortium.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data on COVID-19 deaths were provided by the New York Times and are publicly available: https://github.com/nytimes/covid-19-data/ Data on social-distancing metrics were provided under a Data Use Agreement by SafeGraph and are available by contacting SafeGraph directly: https://www.safegraph.com/dashboard/covid19-shelter-in-place